Transaction · 0001652410-26-000018

Hecht Beth

Hecht Beth, SR, reported an open-market or private sale at Xeris Biopharma Holdings, Inc. involving 16666.000000 shares for an estimated $141434.34. Reported holdings after the transaction were 1127796.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SSR
XERSXeris Biopharma Holdings, Inc.
Filing timeSep 01
Trade dateSep 01, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$8.43
Pre-filing
1mo ago -4.2%1w ago +3.4%1d ago +0.1%
Returns since
7d +0.0%30d +0.0%90d +0.0%180d +0.0%1y +0.0%

XERS price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
XERS since 2026-09-01Filed 2 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001652410-26-000018
Common Stock
Transaction date
Sep 01, 2026
Filed Sep 01, 2026, 10:21 PM · 0d delay
Shares
16.6k sh
$849 per share
Estimated value
-$14.1M
Computed from shares × price
Holdings after
1.12M sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Cluster Selling Direct Ownership 10b5-1 Detected
0score
Filing-only score

0

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

See Remarks

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    The transaction was effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on August 8, 2025.

  2. F2

    The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.390 to $8.600, inclusive. The reporting person undertakes to provide to the Is…

Original filing · 0001652410-26-000018
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

XERS